MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 563 SEK 3.68% Market Closed
Market Cap: 8.3B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Cost of Revenue
-kr954.9m
CAGR 3-Years
-32%
CAGR 5-Years
-24%
CAGR 10-Years
-4%
AddLife AB
STO:ALIF B
Cost of Revenue
-kr6B
CAGR 3-Years
-21%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cost of Revenue
-kr1.1B
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cost of Revenue
-kr794m
CAGR 3-Years
-19%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
G
Genovis AB
STO:GENO
Cost of Revenue
-kr45.2m
CAGR 3-Years
-43%
CAGR 5-Years
-64%
CAGR 10-Years
-12%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cost of Revenue
-kr16.5m
CAGR 3-Years
18%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
No Stocks Found

MedCap AB (publ)
Glance View

Market Cap
8.3B SEK
Industry
Life Sciences Tools & Services

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
423.54 SEK
Overvaluation 25%
Intrinsic Value
Price

See Also

What is MedCap AB (publ)'s Cost of Revenue?
Cost of Revenue
-954.9m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Cost of Revenue amounts to -954.9m SEK.

What is MedCap AB (publ)'s Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%

Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for MedCap AB (publ) have been -32% over the past three years , -24% over the past five years , and -4% over the past ten years .

Back to Top